EP4169522A4 - Composition pharmaceutique contenant une fraction de saururus chinensis, et procédé de préparation de celle-ci - Google Patents
Composition pharmaceutique contenant une fraction de saururus chinensis, et procédé de préparation de celle-ci Download PDFInfo
- Publication number
- EP4169522A4 EP4169522A4 EP21826722.7A EP21826722A EP4169522A4 EP 4169522 A4 EP4169522 A4 EP 4169522A4 EP 21826722 A EP21826722 A EP 21826722A EP 4169522 A4 EP4169522 A4 EP 4169522A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- fraction
- preparation
- pharmaceutical composition
- composition containing
- method therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000534017 Saururus chinensis Species 0.000 title 1
- 238000005194 fractionation Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200073480A KR102499893B1 (ko) | 2020-06-17 | 2020-06-17 | 삼백초 분획물을 포함하는 약학 조성물 및 이의 제조 방법 |
| PCT/KR2021/007582 WO2021256865A1 (fr) | 2020-06-17 | 2021-06-17 | Composition pharmaceutique contenant une fraction de saururus chinensis, et procédé de préparation de celle-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4169522A1 EP4169522A1 (fr) | 2023-04-26 |
| EP4169522A4 true EP4169522A4 (fr) | 2024-02-28 |
Family
ID=79176414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP21826722.7A Pending EP4169522A4 (fr) | 2020-06-17 | 2021-06-17 | Composition pharmaceutique contenant une fraction de saururus chinensis, et procédé de préparation de celle-ci |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230218701A1 (fr) |
| EP (1) | EP4169522A4 (fr) |
| JP (1) | JP2023531210A (fr) |
| KR (1) | KR102499893B1 (fr) |
| CN (1) | CN115715196B (fr) |
| WO (1) | WO2021256865A1 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013191342A1 (fr) * | 2012-06-20 | 2013-12-27 | 영남대학교 산학협력단 | Procédé de préparation d'un produit purifié et d'une fraction de saururus chinensis dépourvus de substance toxique, et composition comprenant le produit purifié en tant que principe actif pour le traitement et la prévention de l'asthme et de maladies allergiques |
| KR101482661B1 (ko) * | 2013-03-06 | 2015-01-19 | 경북대학교 산학협력단 | 삼백초(Ｓａｕｒｕｒｕｓ ｃｈｉｎｅｎｓｉｓ Ｌ.) 추출물을 함유하는 스트레스성 위염 억제용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100569089B1 (ko) * | 2002-07-20 | 2006-04-10 | 주식회사 엘컴사이언스 | 뇌기능 및 인지 기능 개선 활성을 갖는 조성물 |
| KR20050076225A (ko) * | 2004-01-20 | 2005-07-26 | 학교법인 인제학원 | 항산화 및 항염증 활성을 갖는 삼백초 추출물을 포함하는조성물 |
| KR101116828B1 (ko) * | 2009-02-07 | 2012-03-13 | 경북대학교 산학협력단 | 고 함량의 활성형 플라보노이드 화합물의 제조방법 및 이로부터 퀘르세틴의 간편 신속 분리 방법 |
| WO2011099665A1 (fr) * | 2010-02-12 | 2011-08-18 | 주식회사 케이씨아이 | Composition antimicrobienne contenant des extraits d'ingrédients naturels, antiseptique naturel composite et procédé de fabrication associé |
| KR101630908B1 (ko) * | 2013-09-26 | 2016-06-15 | 충북대학교 산학협력단 | 사우서네올 d 화합물을 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 약제학적 조성물 |
| KR20150142213A (ko) | 2014-06-11 | 2015-12-22 | 인제대학교 산학협력단 | 삼백초 수용성 추출물을 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 조성물 |
| CN108601804A (zh) * | 2015-11-06 | 2018-09-28 | 韩国科玛株式会社 | 用于预防和治疗炎性肠病的组合物 |
| KR20170067055A (ko) * | 2015-12-07 | 2017-06-15 | 인제대학교 산학협력단 | 삼백초의 수용성 추출물을 포함하는 Th-1 매개 질환의 치료 또는 예방용 약학적 조성물 및 이의 제조 방법 |
| KR20200073480A (ko) | 2018-12-14 | 2020-06-24 | 허승표 | 온도 조절과 흔들림 완화 기능을 갖춘 유모차 |
| CN110467687A (zh) * | 2019-09-24 | 2019-11-19 | 贵州道庄生物科技有限公司 | 一种白芨多糖胶提取工艺 |
-
2020
- 2020-06-17 KR KR1020200073480A patent/KR102499893B1/ko active IP Right Grant
-
2021
- 2021-06-17 EP EP21826722.7A patent/EP4169522A4/fr active Pending
- 2021-06-17 WO PCT/KR2021/007582 patent/WO2021256865A1/fr unknown
- 2021-06-17 JP JP2022578876A patent/JP2023531210A/ja active Pending
- 2021-06-17 CN CN202180043349.1A patent/CN115715196B/zh active Active
- 2021-06-17 US US18/010,071 patent/US20230218701A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013191342A1 (fr) * | 2012-06-20 | 2013-12-27 | 영남대학교 산학협력단 | Procédé de préparation d'un produit purifié et d'une fraction de saururus chinensis dépourvus de substance toxique, et composition comprenant le produit purifié en tant que principe actif pour le traitement et la prévention de l'asthme et de maladies allergiques |
| KR101482661B1 (ko) * | 2013-03-06 | 2015-01-19 | 경북대학교 산학협력단 | 삼백초(Ｓａｕｒｕｒｕｓ ｃｈｉｎｅｎｓｉｓ Ｌ.) 추출물을 함유하는 스트레스성 위염 억제용 조성물 |
Non-Patent Citations (4)
| Title |
|---|
| KANG CHANG-SOO ET AL: "Study on the Antioxidative and Physiological Activities of Saururus chinensis Extract", JOURNAL OF LIFE SCIENCE, KOREAN SOCIETY OF LIFE SCIENCE, KR, vol. 22, no. 6, 30 June 2012 (2012-06-30), pages 807 - 814, XP053031117, ISSN: 1225-9918, DOI: 10.5352/JLS.2012.22.6.807 * |
| MENG XUE ET AL: "Anti-inflammatory effects of Saururus chinensis aerial parts in murine macrophages via induction of heme oxygenase-1", EXPERIMENTAL BIOLOGY AND MEDICINE, vol. 241, no. 4, 8 February 2016 (2016-02-08), GB, pages 396 - 408, XP093112894, ISSN: 1535-3702, DOI: 10.1177/1535370215614657 * |
| See also references of WO2021256865A1 * |
| YEUN-KYUNG LEE ET AL: "Inhibition of DNA topoisomerases I and II and cytotoxicity by lignans from Saururus chinensis", ARCHIVES OF PHARMACAL RESEARCH, vol. 32, no. 10, 1 October 2009 (2009-10-01), KR, pages 1409 - 1415, XP055600148, ISSN: 0253-6269, DOI: 10.1007/s12272-009-2010-7 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4169522A1 (fr) | 2023-04-26 |
| CN115715196B (zh) | 2024-05-28 |
| KR102499893B1 (ko) | 2023-02-15 |
| KR20210155944A (ko) | 2021-12-24 |
| WO2021256865A1 (fr) | 2021-12-23 |
| JP2023531210A (ja) | 2023-07-21 |
| CN115715196A (zh) | 2023-02-24 |
| US20230218701A1 (en) | 2023-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4047083A4 (fr) | Cellule souche pluripotente, composition pharmaceutique, et procédé de préparation et application | |
| EP3733659A4 (fr) | Dérivé de vinyle aromatique ou d'éthyle aromatique, procédé de préparation associé, intermédiaire, composition pharmaceutique et application | |
| EP3991754A4 (fr) | Conjugué anticorps-médicament, intermédiaire correspondant, procédé de préparation associé, et application correspondante | |
| EP3896062A4 (fr) | Composé d'isoindoline, procédé de préparation, composition pharmaceutique et utilisation du composé d'isoindoline | |
| EP4035657A4 (fr) | Composition de médicament contenant de l'acétate d'abiratérone, son procédé de préparation et son application | |
| EP4006161A4 (fr) | Eau de bouleau fermentée, son procédé de production et son utilisation dans une composition pour application externe sur la peau | |
| EP4056571A4 (fr) | Dérivé de dihydroimidazopyrimidone tricyclique, son procédé de préparation, composition pharmaceutique et son utilisation | |
| EP3964199A4 (fr) | Composition de gel stable ayant une teneur élevée en huile, son procédé de préparation et son application | |
| EP4079734A4 (fr) | Dérivé de triazolopyridazine, son procédé de préparation, composition pharmaceutique associée et utilisation correspondante | |
| EP3753909A4 (fr) | Composition de verre, verre à faible teneur en inclusions, son procédé de préparation et son application | |
| EP3954380A4 (fr) | Composition médicamenteuse auto-émulsifiante à base de polyphénol flavonoïde, son procédé de préparation, composition pharmaceutique associée et application associée | |
| EP3919188A4 (fr) | Produit en bois et procédé de préparation associé | |
| EP3670511A4 (fr) | Composé de tétrahydroprotoberbérine, son procédé de préparation, ses utilisations et composition pharmaceutique | |
| EP4144379A4 (fr) | Composition d'agent de formation de film d'agent de contraste, solution de lipide de formation de film d'agent de contraste et agent de contraste et son procédé de préparation | |
| EP4095132A4 (fr) | Dérivé d'isoindoline, composition pharmaceutique et son utilisation | |
| EP3992197A4 (fr) | Composés à cycles fusionnés polycycliques contenant de l'azote, composition pharmaceutique associée, leur procédé de préparation et leur utilisation | |
| EP4206279A4 (fr) | Caoutchouc fluoré à base d'éther perfluoré modifié, procédé de préparation s'y rapportant et son application | |
| EP3988547A4 (fr) | Dérivé d'indazole, son procédé de préparation et son application pharmaceutique | |
| EP3919189A4 (fr) | Produit en bois et procédé de préparation correspondant | |
| EP4071170A4 (fr) | Composition pharmaceutique, son procédé de préparation et son utilisation | |
| EP4032954A4 (fr) | Composition biopolymère, son procédé de préparation et bioplastique l'utilisant | |
| EP4011375A4 (fr) | Composition pharmaceutique contenant de la nitroxoline, comprimé oral à base de nitroxoline, son procédé de préparation et son utilisation | |
| EP4169522A4 (fr) | Composition pharmaceutique contenant une fraction de saururus chinensis, et procédé de préparation de celle-ci | |
| EP4003306A4 (fr) | Procédés et ensembles pour préparer et distribuer des lyosphères de compositions pharmaceutiques | |
| EP3738582A4 (fr) | Particule solide, son procédé de préparation et composition pharmaceutique contenant des particules solides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20221222 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20240125 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23L 33/105 20160101ALI20240119BHEP Ipc: A61P 1/00 20060101ALI20240119BHEP Ipc: A61P 29/00 20060101ALI20240119BHEP Ipc: A61K 36/78 20060101AFI20240119BHEP |